Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-02 4:30 pm Unchanged | 2022-05-02 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-03-08 08:58 am Unchanged | 2022-03-08 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Arkin Moshe | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-11 6:34 pm Unchanged | 2022-02-11 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-11 5:23 pm Unchanged | 2022-02-11 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Vivo Ventures VI LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-02 7:11 pm Unchanged | 2022-02-02 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BLACKROCK INC BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-21 3:25 pm Unchanged | 2022-01-21 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-09-10 10:31 am Unchanged | 2021-09-10 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-08-06 4:30 pm Unchanged | 2021-08-06 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Vivo Ventures VI LLC | 0 0.000% | 0 (Unchanged) | Filing |